Literature DB >> 2498129

Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes.

J Bauer1, G Lengyel, T M Bauer, G Acs, W Gerok.   

Abstract

Human blood monocytes normally express the interleukin-6 receptor. Treatment of cultured monocytes with endotoxin, interleukin-1 beta, or interleukin-6 results in a decrease in interleukin-6 receptor mRNA levels. Glucocorticoids aso cause a drop in monocytic interleukin-6 receptor mRNA levels. We also found interleukin-6 receptor expression in cultured human hepatocytes, but in contrast to monocytes, where interleukin-6 receptor mRNA is presented by the ligand and by interleukin-1, treatment of hepatocytes with interleukin-6 or interleukin-1 resulted in increased interleukin-6 receptor mRNA levels. Induction of interleukin-6 receptor mRNA in hepatocytes was less pronounced when glucocorticoids were omitted from the culture medium. We conclude that during noninflammatory homeostasis, blood monocytes are involved in binding of trace amounts of circulating interleukin-6. During inflammatory events, the main target of interleukin-6 may be changed from the monocytic population not only to activated B-cells, but also to the hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498129     DOI: 10.1016/0014-5793(89)80008-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 2.  Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth.

Authors:  J Bauer
Journal:  Klin Wochenschr       Date:  1989-07-17

3.  Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells.

Authors:  L Snyers; L De Wit; J Content
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.

Authors:  C B Siegall; R P Nordan; D J FitzGerald; I Pastan
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Interferon-alpha down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266.

Authors:  J C Anthes; Z Zhan; H Gilchrest; R W Egan; M I Siegel; M M Billah
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

6.  The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines.

Authors:  M Hiron; M Daveau; P Arnaud; J Bauer; J P Lebreton
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

7.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures.

Authors:  J J Schroeder; R J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.

Authors:  David A Jackson; Timothy D Smith; Nansalmaa Amarsaikhan; Weiguo Han; Matthew S Neil; Shannon K Boi; Anne M Vrabel; Ezequiel J Tolosa; Luciana L Almada; Martin E Fernandez-Zapico; Sherine F Elsawa
Journal:  J Immunol       Date:  2015-08-03       Impact factor: 5.422

9.  IL-6 induces hepatic inflammation and collagen synthesis in vivo.

Authors:  I Choi; H S Kang; Y Yang; K H Pyun
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide.

Authors:  C Fearns; V V Kravchenko; R J Ulevitch; D J Loskutoff
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.